Back
Autolus Therapeutics PLC Stock Price Chart
Sponsored
AUTL
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
22
AUTL
Autolus Therapeutics PLC
Last Price:
$2.29
Seasonality Move:
-14.07%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing slight buying pressure.
Autolus Therapeutics PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.5 | Sell |
20-day SMA: | 2.84 | Sell |
50-day SMA: | 3.41 | Sell |
200-day SMA: | 4.1 | Sell |
8-day EMA: | 2.48 | Sell |
20-day EMA: | 2.77 | Sell |
50-day EMA: | 3.19 | Sell |
200-day EMA: | 3.86 | Sell |
Autolus Therapeutics PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 28.9 | Sell |
Chaikin Money Flow: | 521617 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.56 - 3.16) | Sell |
Bollinger Bands (100): | (3.08 - 4.24) | Sell |
Autolus Therapeutics PLC Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Autolus Therapeutics PLC Stock
Is Autolus Therapeutics PLC Stock a Buy?
-
Autolus Therapeutics PLC share price is 2.29 while AUTL 8-day simple moving average is 2.50, which is a Sell signal.
-
The stock price of AUTL is 2.29 while Autolus Therapeutics PLC 20-day SMA is 2.84, which makes it a Sell.
-
Autolus Therapeutics PLC 50-day simple moving average is 3.41 while AUTL share price is 2.29, making it a Sell technically.
-
AUTL stock price is 2.29 and Autolus Therapeutics PLC 200-day simple moving average is 4.10, creating a Sell signal.
AUTL Technical Analysis vs Fundamental Analysis
Sell
22
Autolus Therapeutics PLC (AUTL)
is a Sell
Is Autolus Therapeutics PLC a Buy or a Sell?
-
Autolus Therapeutics PLC stock is rated a SellThe current Autolus Therapeutics PLC [AUTL] share price is $2.29. The Score for AUTL is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Autolus Therapeutics PLC Stock Info
Market Cap:
609.4M
Price in USD:
2.29
Share Volume:
2.6M
Autolus Therapeutics PLC 52-Week Range
52-Week High:
7.45
52-Week Low:
2.20
Sell
22
Autolus Therapeutics PLC (AUTL)
is a Sell
Autolus Therapeutics PLC Share Price Forecast
-
What is the Autolus Therapeutics PLC stock price today?The Autolus Therapeutics PLC stock price is 2.29 USD today.
-
Will AUTL stock go up or go down?Autolus Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Autolus Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Autolus Therapeutics PLC is overvalued.
Is Autolus Therapeutics PLC Stock a Buy?
-
Autolus Therapeutics PLC share price is 2.29 while AUTL 8-day exponential moving average is 2.48, which is a Sell signal.
-
The stock price of AUTL is 2.29 while Autolus Therapeutics PLC 20-day EMA is 2.77, which makes it a Sell.
-
Autolus Therapeutics PLC 50-day exponential moving average is 3.19 while AUTL share price is 2.29, making it a Sell technically.
-
AUTL stock price is 2.29 and Autolus Therapeutics PLC 200-day simple moving average is 3.86, creating a Sell signal.
Fundamental Analysis of Autolus Therapeutics PLC
Is Autolus Therapeutics PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.11 per share.
Technical Analysis of Autolus Therapeutics PLC
Should I short Autolus Therapeutics PLC stock?
-
AUTL Moving Average Covergence Divergence (MACD) indicator is -0.29, suggesting Autolus Therapeutics PLC is a Sell
-
Autolus Therapeutics PLC Relative Strength Index (RSI) is 28.9, which suggest Autolus Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Autolus Therapeutics PLC is (2.56 - 3.16), which suggest Autolus Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Autolus Therapeutics PLC is (3.08 - 4.24), which suggest Autolus Therapeutics PLC is a Sell
* Autolus Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.